Prevalence of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Iran: A Systematic Review and Meta-Analysis

Table 1

Characteristics of included studies in the prevalence of cardiovascular disease in patients with type 2 diabetes.

Author [reference]	Year of the data collection	Mean age (years)	City	Sample size	Prevalence (%)	Quality
Janghorbani and Amini [21]	2005	48.3	Isfahan	3202	20.8	High
Abbasian et al. [22]	2006	49.6	Shahroud	400	38.0	High
Abbasian and Delorian [20]	2007	50.2	Shahroud	340	18.5	High
Janghorbani et al. [23]	2006	50.6	Isfahan	1566	28.0	High
Sarshar and Chamanzari [24]	2002	52	Gonabad	136	32.4	High
Hosseini et al. [25]	2014	53.9	Tehran	305	30.5	High
Taherkhani and Safi [26]	2014	54.09	Tehran	104	65.4	High
Kashi et al. [27]	2015	54.4	Sari	1021	27.0	High
Khatoni et al. [28]	2011	58.25	Qasr-e Shirin	286	43.4	High
Kaviani et al. [29]	2013	58.6	Khorramabad	299	41.8	High
Ranjbar et al. [30]	2004	—	Shiraz	392	59.7	Medium
Heshmati et al. [31]	2013	—	Fereydunkenar	400	38.8	High
Ajam et al. [32]	2005	—	Gonabad	347	26.0	Medium
Alfti Far et al. [33]	2017	—	Hamadan	89	45.8	High
Niroumand et al. [34]	2016	—	Northeast of Iran	75	34.7	High
Soltani and Fardin Far [19]	2011	—	Birjand	70	68.6	Medium
Cheraghi et al. [35]	2010	—	Shadegan	521	35.7	Medium